MTE #3: Beyond Steroids—Managing Complex Rejection After Liver Transplantation (Ticketed)

Nov 06 2026

Convention Center: Room 1C

7:00 AM - 7:45 AM

Ticketed Event

CE Credits

World Class Speakers

Mark W. Russo

Discussion Leader

Geoffrey g McCaughan

Discussion Leader

Description

Learn from the experts in this practical, case-based discussion regarding the diagnosis and management of complex liver allograft rejection. Faculty focus on real-world scenarios including antibody-mediated rejection, steroid-resistant T cell-mediated rejection, plasma cell–rich rejection, and chronic rejection. Attendees participate in an informative interactive discussion and learn management pearls for challenging rejection cases.

Objectives

Develop strategies to monitor response to therapy, manage toxicity, and define treatment endpoints in the context of complex rejection after liver transplantation.
Distinguish complex liver allograft rejection phenotypesantibody-mediated rejection, steroid-resistant T cell-mediated rejection, plasma cellrich rejection, and chronic rejectionusing clinical context, histopathology, and donor-specific antibody data.
Appraise practical treatment plans, including escalation beyond steroids and use of adjunctive therapies, in the setting of complex rejection after liver transplantation.